The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 16 of the 20 sources its claims cite were checked for support.
Engineering circular RNA for potent and stable translation in eukaryotic cells
Open accessAbstract
Messenger RNA (mRNA) has broad potential for application in biological systems. However, one fundamental limitation to its use is its relatively short half-life in biological systems. Here we develop exogenous circular RNA (circRNA) to extend the duration of protein expression from full-length RNA messages. First, we engineer a self-splicing intron to efficiently circularize a wide range of RNAs up to 5 kb in length in vitro by rationally designing ubiquitous accessory sequences that aid in splicing. We maximize translation of functional protein from these circRNAs in eukaryotic cells, and we find that engineered circRNA purified by high performance liquid chromatography displays exceptional protein production qualities in terms of both quantity of protein produced and stability of production. This study pioneers the use of exogenous circRNA for robust and stable protein expression in eukaryotic cells and demonstrates that circRNA is a promising alternative to linear mRNA.
Overview
CoChat Summary
## TL;DR
The paper engineers exogenous circular RNA (circRNA) systems that can circularize long RNAs up to 5 kb and drive robust protein expression in eukaryotic cells. Compared with linear mRNA, optimized circRNA showed longer-lasting protein production and, after HPLC purification, stronger protein output in the tested cell lines.
## Key findings
- Adding homology arms to the permuted intron-exon construct increased splicing efficiency from 0% to 16% with weak arms and to 48% with strong arms.
- Rationally designed spacer sequences improved splicing efficiency from 46% to 87%, and a disruptive spacer completely abrogated splicing.
- Using the engineered Anabaena catalytic intron increased splicing efficiency from 84% to 95% and reduced circRNA nicking by 37% relative to the T4 catalytic intron.
- In HEK293 cells, HPLC-purified circRNA produced 811.2% more protein than unmodified linear mRNA at 24 h and 54.5% more than modified linear mRNA; protein-production half-life was 80 h for circRNA versus approximately 43 h and 45 h for the unmodified and modified linear mRNAs, respectively.
- In HeLa cells, circRNA protein-production half-life was 116 h, compared with approximately 44 h and 49 h for the unmodified and modified linear mRNAs.
- The CVB3 IRES was 1.5-fold more effective than the EMCV IRES in HEK293 cells and remained superior across HeLa, A549, and Min6 cells tested.
## Methods
- Engineered circRNAs were built using permuted group I intron/PIE designs with homology arms, spacer sequences, and different IRES elements; constructs included coding regions for GLuc, Firefly luciferase, EGFP, human erythropoietin, and Cas9.
- RNAs were synthesized by in vitro transcription, circularized with GTP/Mg2+-dependent self-splicing, enriched with RNase R, and purified by gel extraction or size-exclusion HPLC; circularization was assessed by gel analysis, RNase H nicking analysis, and splice-junction sequencing.
- Functional testing used transfection into HEK293, HeLa, A549, HEK293-GFP, and Min6 cells, with readouts including luminescence, fluorescence, ELISA, flow cytometry, cytokine assays, and qPCR; statistics were by two-tailed unpaired Welch’s t-test.
## Limitations
- The paper states that longer circRNAs were more prone to nicking during production, which reduced yields and purity.
- The discussion says more work is needed to optimize translation from circRNA and to study translation efficiency and stability in other cell types and tissues.
- The paper notes that additional analysis of exogenous circRNA immunogenicity is required, and that suitable delivery vehicles in vitro and in vivo need thorough investigation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
9 Valid · 1 Not valid · 3 Not checked · 54 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“These strategies have yielded modest improvements in RNA stability10, 13–16, and thus alternative approaches to RNA stabilization, such as circularization, are desirable.”
§ Engineering circular RNA for potent and stable translation in eukaryotic cells > Introduction
What the sources say
- Disputedcites [10] Kaczmarek, J. C., Kowalski, P. S. & Anderson, D. G. Advances in the delivery of RNA therapeutics: from concept to clinical reality. Genome Med. 9, 60 (2017). sourceExperimental — accuracy not yet measured
In the “Protein overexpression—mRNA” section (page not provided), the paper says that cap analogs and poly(A) tails have markedly improved mRNA stability, contrary to the claim that previous strategies yielded only modest improvements. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Disputedcites [13] Holtkamp, S. et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108, 4009–4017 (2006). sourceExperimental — accuracy not yet measured
In the section on combining poly(A)-tail and 3′ UTR modifications (page unavailable), the paper reports an approximately two-orders-of-magnitude improvement in RNA stability relative to standard IVT RNA. That result is contrary to describing the improvement reported by this source as modest. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [14] Kuhn, A. N. et al. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther. 17, 961–971 (2010). source
The RNA half-life results (Table 2) show a limited increase with the phosphorothioate cap in immature dendritic cells compared with conventional capping. The same results section explicitly says functional cap analogs had a modest effect on RNA stability in mature dendritic cells. (LLM, conf=0.84)
- Partly supportedcites [15] Presnyak, V. et al. Codon optimality is a major determinant of mRNA stability. Cell 160, 1111–1124 (2015). sourceExperimental — accuracy not yet measured
The Results section reports that reporters with optimal codons were about fourfold more stable than those with non-optimal codons, supporting an improvement in mRNA stability. The paper does not characterize that improvement as modest or establish that previous stabilization strategies generally yielded only modest gains. (LLM, conf=0.79)
- Could not verifycites [16] Kariko, K., Muramatsu, H., Ludwig, J. & Weissman, D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 39, e142–e142 (2011). sourceExperimental — accuracy not yet measured
The Introduction and Discussion describe reduced immune activation and improved translation with modified or HPLC-purified mRNA, but do not characterize improvements in RNA stability as modest. Searches for RNA stability, half-life, degradation, and circularization found no passage in our copy that establishes the claimed comparison. (LLM, conf=0.74)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, the intervening region between the 5′ and 3′ splice sites of native group I introns is on average 300–500 nucleotides long22, while the intervening region of the engineered RNA that we constructed was two to four-fold longer.”
§ Engineering circular RNA for potent and stable translation in eukaryotic cells > Results > Long RNA circularization is assisted by homology
What the sources say
- Partly supportedcites [22] Vicens, Q., Paukstelis, P. J., Westhof, E., Lambowitz, A. M. & Cech, T. R. Toward predicting self-splicing and protein-facilitated splicing of group I introns. RNA 14, 2013–2029 (2008). sourceExperimental — accuracy not yet measured
The Results section reports that 12 group I introns tested were 183–421 nucleotides long, and Intron selection gives a range of 183–496 nucleotides for introns requested. Neither passage establishes a 300–500-nucleotide average for native group I introns generally. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, we engineer a self-splicing intron to efficiently circularize a wide range of RNAs up to 5 kb in length in vitro by rationally designing ubiquitous accessory sequences that aid in splicing.”
§ Engineering circular RNA for potent and stable translation in eukaryotic cells > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the case of EMCV and Poliovirus IRESs, polyA sequences improved expression beyond the improvement seen with an unstructured polyAC spacer.”
§ Engineering circular RNA for potent and stable translation in eukaryotic cells > Results > The CVB3 IRES is superior in the context of circRNA
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that the IRES from Coxsackievirus B3 (CVB3) was 1.5-fold more effective than the commonly adopted EMCV IRES in HEK293 cells (Fig. 4a).”
§ Engineering circular RNA for potent and stable translation in eukaryotic cells > Results > The CVB3 IRES is superior in the context of circRNA
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
34 more claims
Create a free account to see all 67 claims and every source verdict.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 9
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similar to linear mRNA, the chemical modification of specific nucleotides and chromatographic purification can minimize immunogenicity of the RNA and increase translation.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [245]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Circular RNA (circRNA) is a single-stranded RNA with a closed-loop structure.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [245]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, circular RNA (circRNA) can be synthesized to optimize mRNA properties245,246 (Box 2).”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [245]
In the citing paper
“Despite the lack of essential elements for cap-dependent translation, circRNA can be translated by adding the IRES element or m6A modification incorporated to its 5′ UTR region.223,224”
From Advances in COVID-19 mRNA vaccine development (2022) · cites this paper as [223]
In the citing paper
“Given its enhanced biostability compared with linear RNA due to the lack of terminals preventing degradation,49 circRNA could be a promising research avenue.”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [49]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Exon-intron circular RNAs regulate transcription in the nucleus
Li, Z., Huang, C., Bao, C., Chen, L., Lin, M., Wang, X., Zhong, G., Yu, B., Hu, W., Dai, L., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2959 · Cited by 2,905
Detecting and characterizing circular RNAs
Jeck, W. R., & Sharpless, N. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2890 · Cited by 2,702
Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis
Legnini, I., Di Timoteo, G., Rossi, F., Morlando, M., Briganti, F., Sthandier, O., Fatica, A., Santini, T., Andronache, A., Wade, M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.017 · Cited by 2,173
Regulation of circRNA biogenesis
Chen, L.-L., & Yang, L. (2015) · RNA Biology · doi:10.1080/15476286.2015.1020271 · Cited by 1,953
Pamudurti, N. R., Bartok, O., Jens, M., Ashwal-Fluss, R., Stottmeister, C., Ruhe, L., Hanan, M., Wyler, E., Perez-Hernandez, D., Ramberger, E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.021 · Cited by 1,810
Codon Optimality Is a Major Determinant of mRNA Stability
Presnyak, V., Alhusaini, N., Chen, Y.-H., Martin, S., Morris, N., Kline, N., Olson, S., Weinberg, D., Baker, K. E., Graveley, B. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.029 · Cited by 1,078
Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898
Circular RNAs: analysis, expression and potential functions
Barrett, S. P., & Salzman, J. (2016) · Development · doi:10.1242/dev.128074 · Cited by 859
Enuka, Y., Lauriola, M., Feldman, M. E., Sas-Chen, A., Ulitsky, I., & Yarden, Y. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1367 · Cited by 757
Cited by
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
The expanding regulatory mechanisms and cellular functions of circular RNAs
Chen, L.-L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0243-y · Cited by 1,713
The emerging roles of circRNAs in cancer and oncology
Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00585-y · Cited by 1,256
Past, present, and future of circ RNA s
Patop, I. L., Wüst, S., & Kadener, S. (2019) · The EMBO Journal · doi:10.15252/embj.2018100836 · Cited by 1,225
“However, the magnitude of RIG-1 activation due to exogenous circRNA was challenged by later reports (Wesselhoeft et al , 2018, 2019).”
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127
Self-citation
Metadata
- Authors
- Wesselhoeft, R. A., Kowalski, P. S., & Anderson, D. G.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Corresponding author
- Anderson, Daniel G.
- Venue
- Nature Communications
- Published
- 2018-07-06
- Volume
- 9
- Issue
- 1
- Pages
- 2629-2629
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC6035260
- OpenAlex
- W2811482166
- Cited by
- 853
- References
- 28
- Citations by year
- 2026: 153 · 2025: 159 · 2024: 148 · 2023: 124 · 2022: 90 · 2021: 83 · 2020: 53 · 2019: 35 · 2018: 7
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Nature
- Funders
- DOD | Defense Advanced Research Projects Agency (W32P4Q-13-1-0011)
- Juvenile Diabetes Research Foundation (3-PDF-2017-383-A-N)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- circular RNA, self-splicing introns, mRNA stability, protein expression, eukaryotic translation, exogenous RNA
- MeSH terms
- Internal Ribosome Entry Sites, RNA, Circular, Base Sequence, Catalysis, Cell Line, Chromatography, High Pressure Liquid, Eukaryotic Cells, Exons, Genetic Engineering, Humans, Introns, RNA, RNA Splicing, RNA, Messenger, Sequence Homology, Nucleic Acid, Protein Biosynthesis, Open Reading Frames, Anabaena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Engineering circular RNA for potent and stable translation in eukaryotic cells. https://app.cochat.ai/papers/10.1038/s41467-018-05096-6
- The paper
- Wesselhoeft, R. A., Kowalski, P. S., & Anderson, D. G. (2018). Engineering circular RNA for potent and stable translation in eukaryotic cells. Nature Communications. https://doi.org/10.1038/s41467-018-05096-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.